Ipamorelin Structure-Activity Research: Derived GH Secretagogues
A 1998 J Med Chem study used ipamorelin as a scaffold to develop peptidomimetic GH secretagogue analogs, with some showing oral bioavailability in preclinical models.
A 1998 J Med Chem study used ipamorelin as a scaffold to develop peptidomimetic GH secretagogue analogs, with some showing oral bioavailability in preclinical models.